Alan A. Wiles

A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial

Nurulamin M Noor, James Lee, Simon Bond et al. · ˜The œLancet. Gastroenterology & hepatology · 2024 · 281 citations · Full text

Veterinary Medicine, Immunology, Gastroenterology +16

Biologic Therapy for Inflammatory Bowel Disease: Real-World Comparative Effectiveness and Impact of Drug Sequencing in 13 222 Patients within the UK IBD BioResource

Christina Kapizioni, R Desoki, Danielle Lam et al. · Journal of Crohn s and Colitis · 2023 · 110 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab

Simeng Lin, Nicholas A. Kennedy, Aamir Saifuddin et al. · Nature Communications · 2022 · 81 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Low cost triazatruxene hole transporting material for >20% efficiency perovskite solar cells

Arthur Connell, Zhiping Wang, Yen‐Hung Lin et al. · Journal of Materials Chemistry C · 2018 · 58 citations · Full text

Natural Sciences, Materials Engineering, Materials Science +15

Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study

Zhigang Liu, Kaixing Le, Xin Zhou et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 35 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17